In CRC, FAM134B can suppress the synthesis phase of the cell cycle to decrease the growth rate and modulate with the Wnt/β-catenin signaling pathway to induce an increase in APC and promote the destabilization of β-catenin, inhibiting the transformation of normal mucosa into adenoma [35,36,37]. Here, APC is linked to colorectal carcinoma.